Sleep Apnea Market Clinical Trials and Diagnostic Systems 2015 Pipeline Reviews in New Research Reports

Aug 23, 2015, 22:00 ET from RnR Market Research

PUNE, India, August 24, 2015 /PRNewswire/ --

Market research reports titled Sleep Apnea Global Clinical Trials Review, H2, 2015 and Sleep Apnea Diagnostic Systems - Pipeline Review, 2015 are now available under pharmaceuticals and medical devices segments of

Complete report on sleep apnea market clinical trials review for H2 2015 spread across 90 pages, providing an overview of 20 companies, organizations/institutes, as well as supported with 45 tables and 23 figures is now available at .

The Sleep Apnea Global Clinical Trials Review, H2, 2015 market research report provides provides top line data relating to the clinical trials on Sleep Apnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). These trial reports are generated using a proprietary database in which clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

This sleep apnea market research assists in formulating key business strategies with regards to investment, helps in identifying prominent locations for conducting clinical trials which saves time and cost and provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities. It also supports understanding of trials count and enrollment trends by country in global sleep apnea therapeutics market, aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials and facilitates clinical trial assessment of the indication on a global, regional and country level.

Companies, government organizations and institutes covered in this sleep apnea market clinical trials report include Cephalon, Inc. (Inactive), Merck & Co., Inc., Jazz Pharmaceuticals Plc, Cortex Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., Koninklijke Philips N.V., Bioprojet SCR, Altasciences Company Inc, Alfresa Holdings Corporation, Abbott Laboratories, Brigham and Women's Hospital, Woolcock Institute of Medical Research, Associacao Fundo de Incentivo a Psicofarmcologia, U.S. Department of Veterans Affairs, University of Chicago, Chinese University of Hong Kong, Hospital do Servidor Publico Estadual, Karolinska University Hospital, University of Wisconsin Madison and University of Zurich. Order a copy of Sleep Apnea Global Clinical Trials Review, H2, 2015 market research report at .

The second research titled Sleep Apnea Diagnostic Systems - Pipeline Review, 2015 provides an overview of sleep apnea diagnostic system products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key sleep apnea diagnostic system pipeline products.

Extensive coverage of the sleep apnea diagnostic system products under development is provided in this research that reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities. The report also reviews the major players involved in the development of Sleep Apnea Diagnostic System products and list all their pipeline projects. The coverage of pipeline products in this research is based on various stages of development ranging from Early Development to Approved / Issued stage. The report provides key clinical trial data of ongoing trials specific to pipeline products as well as information on recent developments in the segment / industry.

Sleep apnea diagnostic systems companies mentioned in this report with their product overview include Anaxsys Technology Ltd, ApneaDx Inc., Appian Medical Pty. Ltd., Barron Associates, Inc., Ben-Gurion University of the Negev, Biospeech, Inc., BresoTec Inc., Instituto de investigacion sanitaria Marques de Valdecilla, iSonea (Israel) Limited, K-diagnostics, LifeWave Hi-Tech Medical Devices Ltd., Rest Devices Inc, Revent Medical, Inc., Rice University, SATT South East, Somnarus Inc., The Johns Hopkins University and VSSB Medical Nanotechnology. Supported with 69 tables, 6 figures and spread across 77 pages, the Sleep Apnea Diagnostic Systems - Pipeline Review, 2015 report and its comprehensive table of contents are available at .

On similar lines, also has another research titled Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019. This report says the industry is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany), among others, are some of the key players engaged in this market. Read more at .

Explore more reports on the medical devices market and pharmaceuticals industry at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus:



RSS / Feeds:

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441

SOURCE RnR Market Research